Jim Cramer Says AbbVie Will Benefit Return of Elective Surgeries

Katherine Ross

Jim Cramer says that his Action Alerts PLUS portfolio loves AbbVie.

Just last week, in his daily column over on Real Money, Cramer broke down for investors his thoughts on AbbVie.

"If things are truly getting better and you think that they won't get worse if people come out of their houses and start leading their lives with the exception in a regular fashion, hopefully wearing a mask, which the CDC misled us into thinking didn't work, and practicing physical distancing, then I think it's time to let some businesses open up but maybe close others. In many states doctors and dentists haven't been able to work. They know how to wear masks. It's time for dermatologists to make a living again. In fact, I suggest you own AbbVie (ABBV) , which is buying Allergan (AGN) , in large part because of its botox franchise. It's elective, it's cash pay and it's viewed as a necessity for many," Cramer wrote.

Read the full column here.

Cramer broke it down further for TheStreet's Katherine Ross in the video above. 

Watch the full video above for more.

Want to know what Jim Cramer and his team at Action Alerts PLUS are thinking about the markets and the stocks they're watching? Sign up on Action Alerts PLUS for more.

Cramer and the team are weighing in on what members need to know about the coronavirus pandemic's impact on the market. Here's how you can recap his entire April show.

Watch More of the Latest Videos on TheStreet and Jim Cramer

Enter your email to register or login. Registration information may be shared with advertising partners in accordance with our Privacy Policy.